Updates in the Treatment of Diffuse Large B-cell Lymphoma - Episode 3

Updates in the Treatment of Diffuse Large B-Cell Lymphoma

September 14, 2021

This article discusses the current treatment landscape and therapeutic strategies for relapse/refractory diffuse large B-cell lymphoma (R/R DLBCL), the role of CAR T-cell therapies in R/R DLBCL, and insights on new regimens and ongoing clinical trials from leading experts in hematologic malignancies.

EP. 1: Dr. Flowers on Long-Term Efficacy With Tafasitamab Plus Lenalidomide in DLBCL

EP. 2: Dr. Xavier on Recent Updates in DLBCL

Now Viewing

EP. 3: Updates in the Treatment of Diffuse Large B-Cell Lymphoma